We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu
IMPORTANT: Due to the lapse in government funding, the information on this web site may not be up to date, transactions submitted via the web site may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Inflammatory Markers in Patients With Active Migraine Headaches

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00471861
Recruitment Status : Completed
First Posted : May 10, 2007
Last Update Posted : August 8, 2011
Information provided by:

May 8, 2007
May 10, 2007
August 8, 2011
May 2007
Not Provided
Not Provided
Not Provided
Complete list of historical versions of study NCT00471861 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
Inflammatory Markers in Patients With Active Migraine Headaches
Does Migraine As A Partly Inflammatory Disease Increase The Inflammatory Markers Of The Patient When Actively Having a Migraine?
The purpose of this study is to determine whether C-Reactive Protein (CRP) is elevated in patients with active migraine headaches. Secondary goal is to determine whether other inflammatory markers, such as Calcitonin Gene Peptide (CGRP), Vasoactive Intestinal Polypeptide (VIP) or Substance P (SP) are elevated in patients having a migraine headache.
A random selection of patients both male and female from a primary care practice with a diagnosis of having migraine headaches will be enrolled. Thirty (30) patients will be recruited mainly from the primary care practice. Recruitment will include males and females aged 21-65. The patients who meet the inclusion criteria will be enrolled. The patients who do not have migraine headaches will also be enrolled and function as controls. Non-migraine patients will meet inclusion criteria 1, 2 and 3 and all of the exclusion criteria.
Observational Model: Case-Crossover
Time Perspective: Prospective
Not Provided
Not Provided
Probability Sample
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
February 2009
Not Provided

Inclusion Criteria:

  1. Subjects must sign a written informed consent.
  2. Enrollment population would include males and females 21 years of age to 65 years of age.
  3. Non-migraine subjects will be allowed in the control group
  4. Have episodic migraine headaches
  5. Patients to satisfy the diagnosis of migraine headaches with aura, without aura or mixed.
  6. Must be able to differentiate migraine headaches from other headaches

Exclusion Criteria:

  1. Any medical condition in the opinion of the investigator that would make the subject unsuitable for enrollment.
  2. Basilar or hemiplegic migraine headaches.
  3. Pregnant woman or a nursing mother
  4. History (within 1 year) or current evidence of drug or alcohol abuse.
  5. More than 15 migraine headaches per month
  6. Chronic daily headaches
  7. Chronic use of NSAIDs
  8. Current participation in a research study or within the last 30 days.
Sexes Eligible for Study: All
21 Years to 65 Years   (Adult)
Contact information is only displayed when the study is recruiting subjects
United States
Not Provided
Not Provided
Gary E. Ruoff, Westside Family Medical Center
Westside Family Medical Center, P.C.
Principal Investigator: Gary E Ruoff, MD Westside Family Medical Center, P.C.
Westside Family Medical Center, P.C.
February 2009